Export

EN
FR
Salbutamol
Essential medicine status
Section:
25. Medicines acting on the respiratory tract 25.1. Antiasthmatic and medicines for chronic obstructive pulmonary disease
ATC codes: R03AC02
EMLc
Indication
Asthma ICD11 code: CA23
INN
Salbutamol
Medicine type
Chemical agent
List type
Core (EML)
(EMLc)
Formulations
Parenteral > General injections > IV: 50 µg per mL in 5 mL ampoule (as sulfate)
Respiratory > Inhalation > aerosol: 100 µg per dose (as sulfate) ; 100 µg per dose (as sulfate) metered-dose inhaler
Respiratory > Inhalation > solution: 5 mg per mL (as sulfate) for use in nebulizers
EML status history
First added in 1977 (TRS 615)
Changed in 1979 (TRS 641)
Changed in 1984 (TRS 722)
Changed in 1987 (TRS 770)
Changed in 1991 (TRS 825)
Changed in 2007 (TRS 950)
Changed in 2009 (TRS 958)
Changed in 2011 (TRS 965)
Changed in 2021 (TRS 1035)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
terbutaline (ATC codes: R03CC03)
Patent information
Patents have expired in most jurisdictions
Wikipedia
Salbutamol
DrugBank
Salbutamol
Summary of evidence and Expert Committee recommendations
Following the review of square box listings on the EML and EMLc, the Expert Committee recommended terbutaline be specified as a therapeutic alternatives under the square box listing for salbutamol on the EML and EMLc for this indication.